My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
March 2009
Vol. 19 No. 3
Global ID
New HIV/TB Figures Call for Increased Funding, ID Center Says

The Infectious Diseases Center for Global Health Policy and Advocacy responded to newly released figures on HIV-tuberculosis co-infection with a call to triple the U.S. contribution to the Global Fund to Fight HIV, Tuberculosis, and Malaria, and significantly increase domestic funding for TB control.

On World TB Day, March 24, The World Health Organization (WHO) released its latest estimate of HIV-TB coinfection indicating there were at least 1.37 million cases of HIV-TB co-infection worldwide in 2007—twice as many as WHO’s previous estimates.

In a press release, the Infectious Diseases Center for Global Health Policy and Advocacy noted that these figures come as the Global Fund faces a $5 billion shortfall and may be unable to fund anti-TB programs in nearly 60 countries. Global health advocates are concerned that the Obama administration will flatline vital HIV/AIDS and TB programs as the global recession deepens.

The Center held a teleconference with reporters, featuring Richard Chaisson, MD, director of the Johns Hopkins Center for Tuberculosis Research, and Carol Dukes Hamilton, MD, a professor of medicine at Duke University .

Dr. Hamilton noted that the Centers for Disease Control and Prevention’s budget for TB research has suffered in recent years, even as the global threat of TB grows. Dr. Chaisson talked about the need for new infection control measures and increased funding so that vital anti-TB programs, including those run by the Global Fund to Fight AIDS, TB and Malaria, can do a better job screening people with HIV for TB.

More on HIV/TB from the Center’s New Blog

Get the latest HIV/AIDS and TB news at sciencespeaks.wordpress.com, a new blog launched by the Infectious Diseases Center for Global Health Policy and Advocacy. We want this to be a resource for you to get up-to-date information on what’s happening in the field and what’s happening in Washington, DC.

We hope that you will visit this site and post your comments or questions. Please share the site with your public health students and colleagues. And send any story ideas you have to our resident blogger, Deirdre Shesgreen, at dshesgreen@idsociety.org. She is eager to get news from the front lines and hear about your work to combat global HIV/AIDS and TB.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Top Stories
New Influenza Guidelines Released
CDC Calls for Stepped-up Efforts against Carbapenem-resistant Bugs
Long-awaited FDA Guidance on CAP Drugs Released
IDSA Journal Club
Patient Care and Science
EIN: Better Testing for C. difficile
Drug Approvals, Recalls, Adverse Events Update
Practice Management
Medical Societies Raise Concerns About Medicare Audit Program
Global ID
New HIV/TB Figures Call for Increased Funding, ID Center Says
Policy and Advocacy
IDSA Responds to Supermarketsí Free Antibiotics Promotions
Forum Makes the Case for Medicare Coverage of Home Infusion Therapy
Deadline Extended for Public Input on Lyme Disease Guidelines
Your Colleagues
Welcome New IDSA Members!

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.